Neves, JMCunha, NLencastre, ACabete, J2023-03-082023-03-082022-11An Bras Dermatol . 2022 Nov-Dec;97(6):816-819. doi: 10.1016/j.abd.2021.12.004.http://hdl.handle.net/10400.17/4441engHSAC DERHumansPortugalAdalimumab / therapeutic useAnti-Inflammatory Agents / therapeutic useHidradenitis Suppurativa* / drug therapySeverity of Illness IndexTertiary Care CentersTreating Hidradenitis Suppurativa Patients with Adalimumab: a Real-Life Experience of a Tertiary Care Center in Lisboa, Portugalother10.1016/j.abd.2021.12.004.